Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

After hundreds of patients were given the newer jab and typically lost a fifth of their body weight after 72 weeks ...

Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...

Q. I took Wegovy for a few months last fall until I was unable to find a pharmacy that could fill my prescription. They were ...

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped ...